IP STARS
Login
Subscribe
Free Trial
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Events
Conferences
Awards
Webinars
Conferences
Awards
Webinars
Show Search
Submit Search
Search Query
Menu
Submit Search
Search Query
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Events
Conferences
Awards
Webinars
Conferences
Awards
Webinars
Login
Subscribe
Free Trial
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility
|
Terms of Use
|
Privacy Policy
|
Modern Slavery Statement
Cookies Settings
Life Sciences 2013 (August 2013)
Main
Introduction: The life sciences in 2013
The impact of first to file on life sciences in the US
Interview: Jurgen Dressel, Novartis on patent litigation strategy
US case analysis: Myriad at the Supreme Court
US Supreme Court rejects the ‘scope of the patent’ test
A guide to further medical use inventions at the EPO
How to ensure the safety of biosimilars in India
India: The implications for patent owners of section 3(d)
New criteria for pharmaceutical trade marks in Mexico
Editorial
Features / Articles
Sponsored